Jeff Marc Goldberg

Insider Reports History

Entity
Individual
Location
C/O Akcea Therapeutics, 55 Cambridge Parkway, Ste 100, Cambridge, MA
Signature
/s/ James Kastenmayer, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeff Marc Goldberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aeglea BioTherapeutics, Inc. President and CEO, Director Employee Stock Option (right to buy) 1.88M Nov 29, 2022 Direct

Insider Reports Filed by Jeff Marc Goldberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AGLE Aeglea BioTherapeutics, Inc. Nov 29, 2022 1 $0 4 Dec 1, 2022 President and CEO, Director
AGLE Aeglea BioTherapeutics, Inc. Nov 29, 2022 0 $0 3 Dec 1, 2022 President and CEO, Director